Vertex Pharmaceuticals Inc.
Balance Sheet
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $1.67B | $1.18B | $714.8M | $625.3M | $569.3M | $489.4M | $475.3M | $243.2M |
| Accounts Receivable | $281.3M | $200.4M | $173.8M | $76.0M | $85.5M | $143.3M | $183.1M | $12.5M |
| Inventory | $111.8M | $77.6M | $57.2M | $30.8M | $14.1M | $30.5M | $112.4M | — |
| Total Current Assets | $2.65B | $1.83B | $1.41B | $1.55B | $1.59B | $1.59B | $1.33B | $1.06B |
| Property, Plant & Equipment | $789.4M | $698.4M | $697.7M | $715.8M | $696.9M | $433.6M | $133.2M | $72.3M |
| Goodwill | $50.4M | $50.4M | $50.4M | $39.9M | $31.0M | $31.0M | $31.0M | $26.1M |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $3.55B | $2.90B | $2.50B | $2.33B | $2.32B | $2.76B | $2.20B | $1.73B |
| Liabilities | ||||||||
| Accounts Payable | $74.0M | $61.5M | $74.9M | $71.2M | $49.3M | $101.3M | $74.6M | $35.9M |
| Total Current Liabilities | $807.3M | $792.5M | $506.2M | $368.3M | $397.8M | $432.6M | $392.3M | $474.8M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $1.50B | $1.56B | $1.40B | $1.24B | $962.6M | $1.52B | $1.24B | $1.22B |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-5.12B | $-5.37B | $-5.26B | $-4.71B | $-3.97B | $-3.52B | $-3.41B | $-3.44B |
| Total Stockholders' Equity | $2.03B | $1.16B | $940.0M | $1.08B | $1.36B | $999.2M | $786.8M | $504.0M |